Literature DB >> 26940197

Brain ischemia with Alzheimer phenotype dysregulates Alzheimer's disease-related proteins.

Marzena Ułamek-Kozioł1, Ryszard Pluta2, Anna Bogucka-Kocka3, Sławomir Januszewski1, Janusz Kocki4, Stanisław J Czuczwar5.   

Abstract

There are evidences for the influence of Alzheimer's proteins on postischemic brain injury. We present here an overview of the published evidence underpinning the relationships between β-amyloid peptide, hyperphosphorylated tau protein, presenilins, apolipoproteins, secretases and neuronal survival/death decisions after ischemia and development of postischemic dementia. The interactions of above molecules and their influence and contribution to final ischemic brain degeneration resulting in dementia of Alzheimer phenotype are reviewed. Generation and deposition of β-amyloid peptide and tau protein pathology are essential factors involved in Alzheimer's disease development as well as in postischemic brain dementia. Postischemic injuries demonstrate that ischemia may stimulate pathological amyloid precursor protein processing by upregulation of β- and γ-secretases and therefore are capable of establishing a vicious cycle. Functional postischemic brain recovery is always delayed and incomplete by an injury-related increase in the amount of the neurotoxic C-terminal of amyloid precursor protein and β-amyloid peptide. Finally, we present here the concept that Alzheimer's proteins can contribute to and/or precipitate postischemic brain neurodegeneration including dementia with Alzheimer's phenotype.
Copyright © 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Brain ischemia; Dementia; Presenilins; β-Amyloid peptide

Mesh:

Substances:

Year:  2016        PMID: 26940197     DOI: 10.1016/j.pharep.2016.01.006

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  7 in total

1.  Photobiomodulation for Global Cerebral Ischemia: Targeting Mitochondrial Dynamics and Functions.

Authors:  Ruimin Wang; Yan Dong; Yujiao Lu; Wenli Zhang; Darrell W Brann; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2018-06-27       Impact factor: 5.590

Review 2.  On the Common Journey of Neural Cells through Ischemic Brain Injury and Alzheimer's Disease.

Authors:  Jan Kriska; Zuzana Hermanova; Tomas Knotek; Jana Tureckova; Miroslava Anderova
Journal:  Int J Mol Sci       Date:  2021-09-07       Impact factor: 6.208

3.  Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation.

Authors:  Vanessa Porrini; Ilenia Sarnico; Marina Benarese; Caterina Branca; Mariana Mota; Annamaria Lanzillotta; Arianna Bellucci; Edoardo Parrella; Lara Faggi; Pierfranco Spano; Bruno Pietro Imbimbo; Marina Pizzi
Journal:  Int J Mol Sci       Date:  2017-01-18       Impact factor: 5.923

4.  Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer's Disease.

Authors:  Marzena Ułamek-Kozioł; Janusz Kocki; Anna Bogucka-Kocka; Alicja Petniak; Paulina Gil-Kulik; Sławomir Januszewski; Jacek Bogucki; Mirosław Jabłoński; Wanda Furmaga-Jabłońska; Judyta Brzozowska; Stanisław J Czuczwar; Ryszard Pluta
Journal:  J Alzheimers Dis       Date:  2016-07-27       Impact factor: 4.472

Review 5.  Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.

Authors:  Marzena Ułamek-Kozioł; Stanisław Jerzy Czuczwar; Sławomir Januszewski; Ryszard Pluta
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

Review 6.  Analysis of Amyloid Precursor Protein Function in Drosophila melanogaster.

Authors:  Marlène Cassar; Doris Kretzschmar
Journal:  Front Mol Neurosci       Date:  2016-07-26       Impact factor: 5.639

Review 7.  Tau Protein Dysfunction after Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.